# A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

> **NCT02590250** · — · COMPLETED · sponsor: **Allergan** · enrollment: 250 (actual)

## Conditions studied

- Urinary Incontinence
- Overactive Bladder

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A

## Key facts

- **NCT ID:** NCT02590250
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-16
- **Primary completion:** 2017-08-07
- **Final completion:** 2017-08-07
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2018-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02590250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02590250, "A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02590250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*